SEE
56
6
ADT
53
3
BF.B
33
2
CVX
47
3
SNA
68
-2
MLM
57
6
TRIP
47
3
PAYX
53
2
DE
63
3
HON
67
2
ZION
65
2
R
71
4
BSX
67
-3
EMN
60
4
CPB
30
6
M
37
12
ACN
52
3
NWL
53
3
NRG
49
-3
A
43
2
SEE
56
6
ADT
53
3
BF.B
33
2
CVX
47
3
SNA
68
-2
MLM
57
6
TRIP
47
3
PAYX
53
2
DE
63
3
HON
67
2
ZION
65
2
R
71
4
BSX
67
-3
EMN
60
4
CPB
30
6
M
37
12
ACN
52
3
NWL
53
3
NRG
49
-3
A
43
2
Financhill
Back

Vir Biotechnology Vs. Arbutus Biopharma Industry Stock Comparison

Sell
31

VIR
Vir Biotechnology

Last Price:
7.12
Seasonality Move:
40.94%
Sell
37

ABUS
Arbutus Biopharma

Last Price:
3.51
Seasonality Move:
24.22%
Sell
31
Vir Biotechnology (VIR) is a Sell

Is Vir Biotechnology a Buy, Sell or Hold?

  • The current Vir Biotechnology [VIR] share price is $7.12. The Score for VIR is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • VIR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
Arbutus Biopharma (ABUS) is a Sell

Is Arbutus Biopharma a Buy, Sell or Hold?

  • The current Arbutus Biopharma [ABUS] share price is $3.51. The Score for ABUS is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • ABUS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VIR Stock Price Chart

What is Vir Biotechnology's stock price today?

  • The Vir Biotechnology share price today is $7.12
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VIR is experiencing slight buying pressure.

ABUS Stock Price Chart

What is Arbutus Biopharma's stock price today?

  • The Arbutus Biopharma share price today is $3.51
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABUS is experiencing slight buying pressure.

VIR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.25 Sell
Relative Strength Index (14 RSI): 38.72 Sell
Chaikin Money Flow: 205781 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.14 - 9.3) Sell
Bollinger Bands (100): (7.42 - 9.42) Sell

ABUS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.13 Sell
Relative Strength Index (14 RSI): 34.97 Sell
Chaikin Money Flow: 429896 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.59 - 4.01) Sell
Bollinger Bands (100): (3.58 - 4.12) Sell

VIR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.55 Sell
20-day SMA: 8.39 Sell
50-day SMA: 7.92 Sell
200-day SMA: 9.16 Sell
8-day EMA: 7.51 Sell
20-day EMA: 7.99 Sell
50-day EMA: 8.12 Sell
200-day EMA: 9.38 Sell

ABUS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.54 Sell
20-day SMA: 3.74 Sell
50-day SMA: 3.89 Sell
200-day SMA: 3.38 Buy
8-day EMA: 3.55 Sell
20-day EMA: 3.69 Sell
50-day EMA: 3.8 Sell
200-day EMA: 3.43 Buy

Vir Biotechnology Earnings Growth & VIR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.73 per share, and an increase next year of $0.07 per share.

Arbutus Biopharma Earnings Growth & ABUS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.04 per share.

Vir Biotechnology Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Arbutus Biopharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):